Aducanumab, anti-Alzheimer's drug approved, but doubts remain
Aducanumab could represent a revolution for all Alzheimer's patients, but for now it represents only an element of controversy
Read moreAducanumab could represent a revolution for all Alzheimer's patients, but for now it represents only an element of controversy
Read moreAn FDA study provides reliable evidence: sunscreen chemicals penetrate the blood. And we have no idea ...
Read moreLife Foam stabilizes the patient with internal bleeding and allows his transport to the hospital. A detail that will save millions ...
Read moreSan Francisco bans e-cigarettes: it is the first US city to implement this measure. Here's how it came ...
Read moreTo submit articles, disclose the results of a research or scientific discoveries write to the editorial staff
Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.
© 2022 Near future -
This work is distributed under license Creative Commons Attribution 4.0 International.